Sung‐Hsi Huang

531 citations

34 papers · 301 indexed · h-index 11

Co-authors: Chien‐Ching Hung Hsin‐Yun Sun Yu‐Chung Chuang Shan‐Chwen Chang Wen‐Chun Liu Yu‐Shan Huang Guan‐Jhou Chen Yi‐Chia Huang
Topics: HIV/AIDS drug development and treatment (12 papers)HIV Research and Treatment (8 papers)HIV/AIDS Research and Interventions (8 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: PLoS ONE Hepatology Scientific Reports
Partner nations: Taiwan China Nigeria

In The Last Decade

Sung‐Hsi Huang

33 papers receiving 300 citations

Peers

Countries citing papers authored by Sung‐Hsi Huang

Since Specialization

Citations

This map shows the geographic impact of Sung‐Hsi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Hsi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Hsi Huang more than expected).

Fields of papers citing papers by Sung‐Hsi Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Hsi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Hsi Huang. The network helps show where Sung‐Hsi Huang may publish in the future.

Co-authorship network of co-authors of Sung‐Hsi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Hsi Huang. A scholar is included among the top collaborators of Sung‐Hsi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Hsi Huang. Sung‐Hsi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Forty years of HIV infection and AIDS in Taiwan: Reflection on the past and looking toward the future 2024 ·Journal of Microbiology Immunology and Infection ·Sung‐Hsi Huang,(unknown),(unknown),(unknown),Kuan‐Yin Lin,Guan‐Jhou Chen,Chia‐Chi Lee,(unknown),Chien‐Ching Hung	2
2	PIP2 regulating calcium signal modulates actin cytoskeleton-dependent cytoadherence and cytolytic capacity in the protozoan parasite Trichomonas vaginalis 2023 ·PLoS Pathogens ·Yen‐Ju Chen,(unknown),(unknown),Sung‐Hsi Huang,Heng‐Cheng Hsu,Hong‐Ming Hsu	2
3	Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection 2023 ·International Journal of Infectious Diseases ·(unknown),(unknown),Chi‐Ying Lin,Sung‐Hsi Huang,Jann‐Tay Wang,Yu‐Chung Chuang,Yee‐Chun Chen,Shan‐Chwen Chang	3
4	Polypharmacy and potential drug–drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy 2023 ·International Journal of Antimicrobial Agents ·(unknown),Sung‐Hsi Huang,(unknown),Pei‐Ying Wu,Han‐Yueh Kuo,Chien‐Ching Hung	4
5	Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients 2023 ·Microbiology Spectrum ·Yu‐Shan Huang,Chien‐Yu Cheng,Hsin‐Yun Sun,Shu‐Hsing Cheng,Po‐Liang Lu,Chen‐Hsiang Lee,Yuan‐Ti Lee,Chin-Shiang Tsai,Chia‐Jui Yang,Chun-Eng Liu,(unknown),Shih‐Ping Lin,Sung‐Hsi Huang,Mao‐Wang Ho,Hung-Jen Tang,Chien‐Ching Hung,(unknown)	6
6	Risky sexual practices and hepatitis C viremia among HIV-positive men who have sex with men in Taiwan 2023 ·Journal of Microbiology Immunology and Infection ·(unknown),Guan‐Jhou Chen,Hsin‐Yun Sun,Yi‐Ting Chen,Li‐Hsin Su,(unknown),Sui‐Yuan Chang,Sung‐Hsi Huang,Yi‐Chia Huang,Wang-Da Liu,Kuan‐Yin Lin,Yu‐Shan Huang,Yi‐Ching Su,Wen‐Chun Liu,Chien‐Ching Hung	8
7	Epidemiology, clinical features, and outcomes of strongyloidiasis in Taiwan from 1988 to 2020: A case series and literature review 2022 ·Journal of Microbiology Immunology and Infection ·(unknown),Hong‐Ming Hsu,(unknown),(unknown),Sung‐Hsi Huang,Chien‐Ching Hung,Kua‐Eyre Su	3
8	Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection 2022 ·Biomedicine & Pharmacotherapy ·Yu‐Chung Chuang,(unknown),Jann‐Tay Wang,Jia‐Ling Yang,Chi‐Ying Lin,Sung‐Hsi Huang,Yee‐Chun Chen,Shan‐Chwen Chang	2
9	The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection 2022 ·Journal of Infection and Public Health ·Yu‐Chung Chuang,Jann‐Tay Wang,(unknown),Chi‐Ying Lin,Sung‐Hsi Huang,Yee‐Chun Chen,Shan‐Chwen Chang	7
10	Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy 2021 ·International Journal of Infectious Diseases ·Guan‐Jhou Chen,Hsin‐Yun Sun,Sui‐Yuan Chang,Aristine Cheng,Yu‐Shan Huang,Sung‐Hsi Huang,Yi‐Chia Huang,Yi‐Ching Su,Wen‐Chun Liu,Chien‐Ching Hung	17
11	Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV 2021 ·International Journal of Antimicrobial Agents ·Yu-Lin Lee,Kuan‐Yin Lin,Shu‐Hsing Cheng,Po‐Liang Lu,Ning‐Chi Wang,Mao‐Wang Ho,Chia‐Jui Yang,(unknown),Hung-Jen Tang,(unknown),Sung‐Hsi Huang,Tun‐Chieh Chen,Chi‐Ying Lin,Shih‐Ping Lin,(unknown),(unknown),Chien‐Ching Hung	6
12	Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018 2020 ·PLoS neglected tropical diseases ·Sung‐Hsi Huang,Mao‐Song Tsai,Chun-Yuan Lee,Chin-Shiang Tsai,Chun-Eng Liu,Yuan‐Ti Lee,(unknown),(unknown),(unknown),Wan‐Chen Tsai,Wei‐Ting Hsu,Wang-Da Liu,Chia‐Jui Yang,Hsin‐Yun Sun,Wen‐Chien Ko,Po‐Liang Lu,Chien‐Ching Hung,(unknown)	14
13	Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018 2020 ·Journal of Microbiology Immunology and Infection ·(unknown),Hsin‐Yun Sun,Szu‐Min Hsieh,Wang‐Huei Sheng,Yu‐Chung Chuang,Yu‐Shan Huang,Sung‐Hsi Huang,Li‐Hsin Su,Yi‐Ching Su,Wen‐Chun Liu,Sui‐Yuan Chang,Chien‐Ching Hung	1
14	Lumbar puncture for non-HIV-infected non-transplant patients with cryptococcosis: Should it be mandatory for all? 2019 ·PLoS ONE ·Sung‐Hsi Huang,Yu‐Chung Chuang,Yi‐Chien Lee,Chien‐Ching Hung,Wang‐Huei Sheng,Jen-Jen Su,Hsin‐Yun Sun,Yee‐Chun Chen,Shan‐Chwen Chang	5
15	Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan 2019 ·BMJ Open ·Yi‐Chia Huang,Hsin‐Yun Sun,Yu‐Chung Chuang,Yu‐Shan Huang,Kuan‐Yin Lin,Sung‐Hsi Huang,Guan‐Jhou Chen,(unknown),Pei‐Ying Wu,Wen‐Chun Liu,Chien‐Ching Hung,Shan‐Chwen Chang	29
16	Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection 2019 ·Hepatology International ·Yu‐Shan Huang,Hsin‐Yun Sun,Sui‐Yuan Chang,Yu‐Chung Chuang,Aristine Cheng,Sung‐Hsi Huang,Yi‐Chia Huang,Guan‐Jhou Chen,Kuan‐Yin Lin,Yi‐Ching Su,Wen‐Chun Liu,Chien‐Ching Hung	19
17	Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection 2019 ·Liver International ·Wan‐Chen Tsai,Wei‐Ting Hsu,(unknown),Hsin‐Yun Sun,Yu‐Chung Chuang,Yu‐Shan Huang,Aristine Cheng,Kuan‐Yin Lin,Yi‐Chia Huang,Guan‐Jhou Chen,Sung‐Hsi Huang,Wang‐Huei Sheng,Szu‐Min Hsieh,Chien‐Ching Hung,Shan‐Chwen Chang	15
18	Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study 2018 ·Journal of Microbiology Immunology and Infection ·Sung‐Hsi Huang,Shu‐Wen Lin,Sui‐Yuan Chang,Ya‐Ting Lin,Hsin‐Yun Sun,Wen‐Chun Liu,Yi‐Ching Su,Chien‐Ching Hung,Shan‐Chwen Chang	4
19	Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy 2017 ·Scientific Reports ·Sung‐Hsi Huang,Shu‐Wen Lin,Sui‐Yuan Chang,Ya‐Ting Lin,(unknown),Chin‐Fu Hsiao,Hsin‐Yun Sun,Wen‐Chun Liu,Yi‐Ching Su,Chien‐Ching Hung,Shan‐Chwen Chang	7
20	Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012–2013 2015 ·Journal of Microbiology Immunology and Infection ·Sung‐Hsi Huang,Yee‐Chun Chen,Yin-Ching Chuang,Sheng-Kang Chiu,Chang‐Phone Fung,Po‐Liang Lu,Lih-Shinn Wang,Tsu‐Lan Wu,Jann‐Tay Wang	24

About Sung‐Hsi Huang

Sung‐Hsi Huang is a scholar working on Virology, Infectious Diseases and Clinical Biochemistry, having authored 34 papers that have together received 301 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (8 papers). The work is most often cited by research in Virology (81 citations), Infectious Diseases (201 citations) and Hepatology (76 citations). Sung‐Hsi Huang has collaborated with scholars based in Taiwan, China and Nigeria. Frequent co-authors include Chien‐Ching Hung, Hsin‐Yun Sun, Yu‐Chung Chuang, Shan‐Chwen Chang, Wen‐Chun Liu, Yu‐Shan Huang, Guan‐Jhou Chen, Yi‐Chia Huang, Yee‐Chun Chen and Kuan‐Yin Lin. Their work appears in journals such as PLoS ONE, Hepatology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact